Literature DB >> 2434580

Beta interferon produced by keratinocytes in human cutaneous infection with herpes simplex virus.

J W Torseth, B J Nickoloff, T Y Basham, T C Merigan.   

Abstract

beta Interferon (IFN) was demonstrated by specific, sequential antibody-neutralization assays of vesicle fluids from patients with recurrent skin lesions due to herpes simplex virus. To determine the origin of this antiviral activity, we cultured keratinocytes from normal facial skin and infected them with three strains of herpes simplex virus. Keratinocyte cultures then developed characteristic cytopathic changes, and antiviral activity was found in culture supernatant media. All such activity from these supernatants was neutralized with specific antiserum to IFN-beta but not with antiserum to IFN-alpha. No IFN-gamma was detectable by radioimmunoassay. Immunoperoxidase staining with antiserum to IFN-beta in five biopsy specimens from culture-proven, recurrent herpes simplex lesions showed positive staining of epidermal keratinocytes but not of dermal or infiltrating cells. Thus, the primary sources of IFN-beta in recurrent herpes lesion vesicles are the virus-infected keratinocytes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2434580     DOI: 10.1093/infdis/155.4.641

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

1.  Interferon-Gamma Enhances TLR3 Expression and Anti-Viral Activity in Keratinocytes.

Authors:  A I Kajita; Shin Morizane; Tetsuya Takiguchi; Takenobu Yamamoto; Masao Yamada; Keiji Iwatsuki
Journal:  J Invest Dermatol       Date:  2015-03-30       Impact factor: 8.551

2.  Role of keratinocytes in human recurrent herpetic lesions. Ability to present herpes simplex virus antigen and act as targets for T lymphocyte cytotoxicity in vitro.

Authors:  A L Cunningham; J R Noble
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

3.  Effect of recombinant mouse interferon-beta on acute and latent herpes simplex infection in mice.

Authors:  M Yamada; Y Arao; A Hatano; F Uno; S Nii
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

4.  Tissue-resident T cell-derived cytokines eliminate herpes simplex virus-2-infected cells.

Authors:  Pavitra Roychoudhury; David A Swan; Elizabeth Duke; Lawrence Corey; Jia Zhu; Veronica Davé; Laura Richert Spuhler; Jennifer M Lund; Martin Prlic; Joshua T Schiffer
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

5.  Detection of IL-1 beta, TNF-alpha, and IL-6 gene transcription by the polymerase chain reaction in keratinocytes, Langerhans cells and peritoneal exudate cells during infection with herpes simplex virus-1.

Authors:  E Sprecher; Y Becker
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

6.  Rapid host immune response and viral dynamics in herpes simplex virus-2 infection.

Authors:  Joshua T Schiffer; Lawrence Corey
Journal:  Nat Med       Date:  2013-03       Impact factor: 53.440

7.  A systematic analysis of host factors reveals a Med23-interferon-λ regulatory axis against herpes simplex virus type 1 replication.

Authors:  Samantha J Griffiths; Manfred Koegl; Chris Boutell; Helen L Zenner; Colin M Crump; Francesca Pica; Orland Gonzalez; Caroline C Friedel; Gerald Barry; Kim Martin; Marie H Craigon; Rui Chen; Lakshmi N Kaza; Even Fossum; John K Fazakerley; Stacey Efstathiou; Antonio Volpi; Ralf Zimmer; Peter Ghazal; Jürgen Haas
Journal:  PLoS Pathog       Date:  2013-08-08       Impact factor: 6.823

Review 8.  Herpes Simplex Virus Type 1 Interactions with the Interferon System.

Authors:  Kevin Danastas; Monica Miranda-Saksena; Anthony L Cunningham
Journal:  Int J Mol Sci       Date:  2020-07-21       Impact factor: 5.923

Review 9.  Cytokines and chemokines: The vital role they play in herpes simplex virus mucosal immunology.

Authors:  Jacinta B Smith; Jason J Herbert; Naomi R Truong; Anthony L Cunningham
Journal:  Front Immunol       Date:  2022-09-23       Impact factor: 8.786

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.